Tech Company Financing Transactions
Juniper Biomedical Funding Round
On 4/2/2024, Juniper Biomedical received $3 million in Seed funding from Auroral Holdings, ATMA Capital and Beacon Angels.
Transaction Overview
Company Name
Announced On
4/2/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to further enhance its expansion plans and solidify its position in the ecosystem, developing innovative neuromodulation solutions.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
UMASS Medical School 55 Lake Avenue North
Worcester, MA 01655
USA
Worcester, MA 01655
USA
Phone
Undisclosed
Website
Email Address
Overview
Juniper Biomedical's precision neuromodulation platform will offer patients less invasive, safer, and more effective therapy options with the unique capabilities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Constantine
Chief Marketing Officer
Nicole Shugrue
Chief Scientific Officer
Mario Romero-Ortega
Chief Technical Officer
Gregory Martin
VP - R & D
Jayme Coates
Browse more venture capital transactions:
Prev: 4/2/2024: Luminance venture capital transaction
Next: 4/2/2024: Seso venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs